lrsam1 Charcot-Marie-Tooth disease neuropathy type 2P (often shortened to CMT2P) is a very rare, inherited nerve disease. It mainly affects the long nerves of the legs, feet, hands, and arms. These nerves are called “peripheral nerves.” In CMT2P, the nerve fiber itself (the axon) slowly becomes damaged. This makes the muscles weak and thin and reduces feeling in the skin.Genetic Rare Diseases Center+2MalaCards+2
CMT2P is caused by harmful changes (mutations) in a gene called LRSAM1. This gene gives instructions for making a protein that works as an E3 ubiquitin ligase, which helps control and recycle other proteins inside nerve cells. When this protein does not work properly, peripheral nerves become more likely to get sick and die back, especially in the longest nerves to the feet and hands.PMC+2Wikipedia+2
CMT2P is an axonal type of Charcot-Marie-Tooth disease. “Axonal” means that nerve conduction speed is often near normal, but the nerve signals are weaker because many axons are lost. People usually develop symptoms in the teenage years or in adult life. The illness usually gets worse slowly over many years.Europe PMC+2Nature+2
Other names for lrsam1 Charcot-Marie-Tooth disease neuropathy type 2P
Doctors and researchers use several different names for this same condition. These names can look confusing, but they all point to the same disorder:
Charcot-Marie-Tooth disease axonal type 2P – this name stresses that the disease is axonal and belongs to type 2.Genetic Rare Diseases Center+1
Charcot-Marie-Tooth disease type 2P (CMT2P) – this is the short genetic type label used in many medical papers and databases.MalaCards+1
LRSAM1-related Charcot-Marie-Tooth disease – this name highlights that the problem comes from changes in the LRSAM1 gene.PMC+1
Charcot-Marie-Tooth neuropathy type 2P or CMT neuropathy type 2P – these names emphasize that it is mainly a neuropathy (nerve disease).MalaCards+1
Former CMT type 2G linked to LRSAM1 – older reports used “CMT2G,” but later research showed that these cases are better grouped as CMT2P caused by LRSAM1 mutations.Idival+1
Knowing these other names is important because different articles and labs may use different labels, but they are talking about the same genetic condition.
Types of lrsam1 Charcot-Marie-Tooth disease neuropathy type 2P
Doctors do not divide CMT2P into official “types” like Type A, B, C, but they describe useful patterns. These patterns help explain how the disease can appear in different families:
Autosomal dominant CMT2P
In this form, one changed copy of the LRSAM1 gene is enough to cause disease. A parent with the mutation has a 50% chance of passing it to each child. Symptoms are often mild to moderate and start in teenage years or adult life.PMC+2Springer Link+2Autosomal recessive CMT2P
In this pattern, a person must inherit two changed copies of the gene (one from each parent). Parents are usually healthy carriers. Disease can start earlier and may be more severe, but reported families are very rare.Genetic Rare Diseases Center+2MalaCards+2Early-onset CMT2P
In some families, signs appear in childhood or adolescence, with earlier walking problems and sensory loss. This can be linked to specific mutations in LRSAM1 that are especially damaging.ScienceDirect+2Springer Link+2Adult-onset slowly progressive CMT2P
In many cases, symptoms start in the 20s–40s. Weakness and numbness progress very slowly over decades. Some people may have only mild difficulties throughout life.PMC+2Europe PMC+2CMT2P with extra features (such as ataxia or Parkinsonism)
A few reports show people with LRSAM1 mutations who have both CMT2P and other problems such as balance issues (ataxia) or Parkinson-like symptoms later in life. These are rare but show that the same gene can affect other parts of the nervous system.Nature+2PMC+2
These patterns are still being studied. Research is ongoing to better link exact LRSAM1 changes with the way the disease looks in each person or family.
Causes of lrsam1 Charcot-Marie-Tooth disease neuropathy type 2P
Pathogenic mutations in the LRSAM1 gene
The main and direct cause of CMT2P is a harmful mutation in the LRSAM1 gene. This mutation changes the structure of the LRSAM1 protein, so it cannot do its normal job of tagging other proteins for recycling in nerve cells. This leads to gradual damage and loss of long peripheral nerves, especially in the legs and feet.PMC+2Wikipedia+2Autosomal dominant inheritance
In many families, CMT2P follows an autosomal dominant pattern. This means one faulty gene copy is enough to cause disease. People in several generations may have similar symptoms because the mutation is passed from parent to child.MalaCards+2Springer Link+2Autosomal recessive inheritance
Some families show autosomal recessive CMT2P. In this case, both copies of LRSAM1 are changed. Parents carry one copy each and usually have no symptoms. A child gets the disease only if both changed copies come together in one person.Genetic Rare Diseases Center+2MalaCards+2Frameshift mutations in the RING domain of LRSAM1
Several patients with CMT2P have frameshift mutations in the RING domain of LRSAM1. This region is essential for E3 ligase activity. A frameshift changes the reading frame of the protein and usually makes it non-functional, which strongly affects nerve health.PMC+2PMC+2Missense mutations in LRSAM1
Other families carry missense mutations, where a single amino acid in the protein is replaced by another. Even this small change can disturb how LRSAM1 binds to its partners and handles cargo proteins, leading to nerve degeneration over time.ScienceDirect+2Springer Link+2Loss of E3 ubiquitin ligase function
The LRSAM1 protein adds ubiquitin tags to other proteins to send them for recycling. When this function is lost or reduced, mis-folded or damaged proteins build up in nerve cells. This stresses the cell and contributes to axonal degeneration.PMC+2Wikipedia+2Disturbed intracellular trafficking in neurons
LRSAM1 is involved in endocytosis and sorting of membrane proteins. Faulty trafficking can disturb communication between the nerve cell body and the axon, especially in long nerves. Over years this leads to length-dependent axonal loss starting in the feet.PMC+1Length-dependent vulnerability of long peripheral nerves
Long nerves to the feet and hands are more sensitive to problems in transport and protein handling. In CMT2P, this length-dependent vulnerability explains why symptoms begin in the toes and feet and only later move up the legs and into the hands.Europe PMC+2Charcot-Marie-Tooth Association+2Family history of CMT2P or related CMT2
Having relatives with CMT2P or other forms of axonal CMT2 greatly raises the chance of carrying an LRSAM1 mutation. Family history does not “cause” the mutation but shows that the mutation is present and inherited.MalaCards+2Europe PMC+2De novo (new) LRSAM1 mutation
In a few cases, a person may be the first in the family to have a pathogenic LRSAM1 mutation. This is called a de novo mutation. It occurs when the gene change appears for the first time in a sperm cell, an egg cell, or very early after conception.UpToDate+1Modifier genes that affect nerve health
Other genes that help maintain axons may change how severe CMT2P becomes. While the main cause is still the LRSAM1 mutation, these “modifier” genes may explain why some people in the same family are more affected than others. This idea is supported by broader CMT research.UpToDate+2Europe PMC+2Age-related axonal fragility
As people age, axons naturally become more fragile. In someone with an LRSAM1 mutation, this normal age-related change can speed up the onset or progression of neuropathy, especially in middle or older age.Europe PMC+1Metabolic stress on nerves (for example, diabetes)
Diabetes does not cause CMT2P, but if a person with CMT2P also has diabetes, the diabetic nerve damage can make the inherited neuropathy much worse. Doctors must separate the effects of both conditions when they evaluate the patient.Mayo Clinic+2Europe PMC+2Nutritional deficiencies (such as vitamin B12 deficiency)
Lack of vitamin B12 or other key nutrients can cause extra nerve damage on top of CMT2P. Again, this does not create the genetic disease but adds another layer of axonal injury, which may make symptoms appear earlier or more severe.Europe PMC+1Exposure to neurotoxic chemicals
Studies in mice show that loss of Lrsam1 makes peripheral axons more sensitive to chemicals like acrylamide that damage nerves. This suggests that toxins may have a stronger effect in people with LRSAM1 mutations, although human data are limited.Nature+1Certain medications that worsen neuropathy
Some chemotherapy drugs or other neurotoxic medicines may cause or worsen peripheral neuropathy. In a person already carrying an LRSAM1 mutation, this extra stress could increase weakness and numbness. Doctors try to avoid or carefully monitor such medicines.Europe PMC+1Mechanical nerve compression
Long-standing pressure on nerves, for example at the ankle or knee, can produce extra nerve damage. A person with CMT2P is more vulnerable to such compression because their nerves are already weak.Europe PMC+1Co-existing autoimmune neuropathy
Very rarely, a person can have both a genetic neuropathy and an acquired autoimmune attack on nerves. The acquired process does not cause CMT2P but can suddenly worsen symptoms, making the underlying LRSAM1-related neuropathy more obvious.PMC+1Co-existing central nervous system disease (for example Parkinsonism)
In some families, a LRSAM1 mutation has been linked with both CMT2P and Parkinson-like symptoms. The same gene defect may disturb both peripheral and central nervous systems, making the overall neurological picture more complex.Wiley Online Library+2PMC+2Unknown or not yet discovered LRSAM1 variants
Genetic research is still finding new LRSAM1 variants. Some may later be proven pathogenic. Until then, they are called “variants of uncertain significance.” They remind us that some causes of CMT2P are still being discovered.ScienceDirect+2UniProt+2
Symptoms of lrsam1 Charcot-Marie-Tooth disease neuropathy type 2P
Weakness in the feet and ankles
The earliest and most common symptom is weakness in the small muscles of the feet and ankles. People may find it harder to stand on toes, climb stairs, or run. This happens because the long motor nerves that control these muscles are damaged.Genetic Rare Diseases Center+2Mayo Clinic+2Foot drop and tripping
As ankle muscles weaken, the front part of the foot does not lift properly during walking. This is called foot drop. It makes tripping over small obstacles very easy, and people may say they are clumsy.Mayo Clinic+2Muscular Dystrophy Association+2Muscle wasting in the lower legs
Over time, muscles in the lower legs become thinner. The calves may look smaller and more bony. This “distal muscle wasting” is typical in axonal CMT2, including CMT2P, because the nerve supply to these muscles slowly dies back.Genetic Rare Diseases Center+2MalaCards+2Loss of sensation in the feet and legs
Many people with CMT2P lose feeling in their feet and lower legs. They may not feel light touch, pain, or temperature well. This numbness can cause injuries or ulcers because small cuts or blisters are not noticed.Genetic Rare Diseases Center+2MalaCards+2Reduced vibration sense and poor body position sense (proprioception)
A key feature in CMT2P is reduced vibration sense, especially at the ankles. People also lose some sense of where their feet are in space, which is called proprioception. This makes walking in the dark or on uneven ground more difficult.Genetic Rare Diseases Center+2CMT Research Foundation+2Mild sensory loss in the fingertips and hands
While the legs and feet are more severely affected, many people also develop numbness or tingling in the fingertips. This can make fine hand tasks such as buttoning shirts or handling small objects harder.Genetic Rare Diseases Center+2MalaCards+2Weakness and wasting in the hands
Later in the disease, small hand muscles can also become weak and thin. Grip strength may decrease, and tasks such as opening jars, writing, or carrying bags can become more difficult.MalaCards+2Europe PMC+2Muscle cramps and fasciculations (muscle twitches)
Younger patients especially may notice leg cramps or small involuntary twitches in the muscles, called fasciculations. These signs show that the motor nerves are irritable and not working normally.Genetic Rare Diseases Center+2MalaCards+2Foot deformities (pes cavus and hammertoes)
Because of long-lasting muscle imbalance around the foot, the arches may become very high (pes cavus), and toes may curl (hammertoes). These deformities are common in many forms of CMT and can also appear in CMT2P.Mayo Clinic+2Charcot-Marie-Tooth Association+2Reduced or absent tendon reflexes
When the doctor taps the knee or ankle tendon with a hammer, the usual reflex response may be weak or missing. This happens because the reflex arc depends on healthy peripheral nerves, which are damaged in CMT2P.MalaCards+2Europe PMC+2Gait imbalance and unsteady walking
Because of weakness, numbness, and poor proprioception, many people develop an unsteady gait. They may sway, especially with eyes closed, and may need to watch their feet while walking to stay balanced.CMT Research Foundation+2Charcot-Marie-Tooth Association+2Neuropathic pain or discomfort
Some people experience burning, tingling, or shooting pains in their feet and legs. This neuropathic pain comes from damaged sensory nerves sending abnormal signals to the brain. Not everyone has pain, but for some it is a major symptom.Europe PMC+2UpToDate+2Fatigue and reduced stamina
Walking and standing require more effort when muscles are weak and balance is poor. Many people with CMT2P feel tired more easily and may avoid long walks or standing for long periods.Muscular Dystrophy Association+2NINDS+2Autonomic symptoms (urinary urgency, erectile problems)
Some reports in CMT2P describe mild autonomic problems such as urinary urgency or erectile dysfunction. These occur because certain autonomic nerve fibers that control bladder and sexual function may also be affected.MalaCards+2Springer Link+2Rare additional neurological symptoms (for example tremor or Parkinson-like features)
In a few families, the same LRSAM1 mutation is linked to both peripheral neuropathy and Parkinson-like symptoms (slowness, stiffness, tremor) in later adulthood. This is uncommon but important because it shows a broader effect of the gene on the nervous system.Wiley Online Library+2PMC+2
Diagnostic tests
Physical exam
Doctors start by taking a careful history and doing a detailed physical and neurologic exam. This may include several simple bedside tests.
General neurologic examination
The doctor looks at muscle size, strength, reflexes, and sensation in the arms and legs. They compare right and left sides and check which areas are more affected. This exam helps decide if the problem is in the peripheral nerves, spinal cord, muscles, or brain, and often already points strongly toward a CMT-type neuropathy.PMC+2Europe PMC+2Focused muscle strength testing in feet, legs, hands, and arms
The doctor asks the patient to push or pull against resistance at the ankle, knee, wrist, and fingers. Muscles that lift the foot, move the toes, or grip objects are tested. Selective weakness in these distal muscles is typical for axonal CMT2, including CMT2P.Europe PMC+2Charcot-Marie-Tooth Association+2Sensory examination for touch, pain, temperature, and vibration
Light touch is checked with cotton, pinprick with a small sharp object, temperature with warm and cold tools, and vibration with a tuning fork over the ankle or toe. In CMT2P, vibration sense and proprioception are often reduced early, especially in the legs, while other sensations may also be lowered.Genetic Rare Diseases Center+2MalaCards+2Gait and balance assessment
The doctor watches the person walk normally, on heels, and on toes, and may ask them to walk in a straight line placing one foot in front of the other. Standing with feet together and eyes closed (Romberg test) shows how much the person depends on vision. People with CMT2P often show foot drop, high-stepping gait, and sway with eyes closed.CMT Research Foundation+2Charcot-Marie-Tooth Association+2
Manual tests
Manual tests are simple, hands-on checks done without machines. They help to quantify function and guide more advanced studies.
Manual Muscle Testing (MMT)
The examiner grades each muscle group on a scale (for example 0–5) by feeling how strongly the patient can push or pull against resistance. This gives a clear picture of which muscle groups are weak and how severe the weakness is. In CMT2P, distal muscles score lower than proximal muscles.PMC+1Balance and coordination tests
Tasks such as standing on one leg, walking heel-to-toe, or changing direction quickly show how much proprioception and strength are affected. Difficulty with these tasks, especially with eyes closed, supports a diagnosis of length-dependent sensory-motor neuropathy.CMT Research Foundation+2NINDS+2Functional hand tests
The doctor may ask the patient to button a shirt, pick up small objects, or write. These tasks reveal subtle hand weakness and sensory loss that might not be obvious in daily life but are typical in later stages of CMT2P.Muscular Dystrophy Association+2Europe PMC+2Manual foot and ankle examination
By gently moving the joints of the feet and ankles, the examiner can see if there are contractures or deformities such as high arches or hammertoes. They also check for joint stiffness and pain. These findings support a chronic neuropathy like CMT and help guide physiotherapy and orthotic treatment.Mayo Clinic+2Orthobullets+2
Lab and pathological tests
Lab and tissue tests help rule out other causes of neuropathy and confirm the genetic diagnosis.
Basic blood tests (screening for other neuropathies)
Blood tests such as complete blood count, blood sugar, kidney and liver function, vitamin B12 levels, and thyroid function are often done. They help exclude common acquired causes of neuropathy like diabetes, kidney disease, B12 deficiency, or thyroid disorders, which can mimic or worsen genetic CMT.Europe PMC+2PMC+2Genetic panel testing for Charcot-Marie-Tooth disease
Many labs offer multigene panels that test several CMT-related genes at once, including LRSAM1. Finding a known pathogenic mutation in LRSAM1 in someone with typical symptoms strongly confirms the diagnosis of CMT2P. Genetic counseling is recommended to help the family understand the result.PMC+2Springer Link+2Targeted LRSAM1 gene sequencing
If CMT2P is strongly suspected, or if a family is already known to have a specific LRSAM1 mutation, targeted sequencing of this gene alone may be used. This test carefully reads the coding portions and splice sites of LRSAM1 to detect single-base changes, small deletions, or insertions.ScienceDirect+2PMC+2Whole-exome or whole-genome sequencing
In complex cases, doctors may order broader sequencing to search for rare or new mutations, including in LRSAM1 and many other genes. This approach is useful when standard panels do not find a cause but a hereditary neuropathy is still strongly suspected.UpToDate+2genecards.org+2Nerve biopsy (usually sural nerve)
In difficult or unclear cases, a small piece of a sensory nerve in the lower leg (the sural nerve) can be removed and examined under a microscope. In axonal CMT2, the biopsy often shows loss of myelinated axons with relatively preserved myelin thickness. Today, biopsy is used less often because genetic tests are more accurate and less invasive.PMC+2Europe PMC+2Skin biopsy for nerve fiber density
A small skin sample can be used to measure tiny nerve fibers in the skin. Reduced intra-epidermal nerve fiber density supports a diagnosis of peripheral neuropathy. This test is more common in research and specialized centers.Europe PMC+1Cerebrospinal fluid (CSF) examination
Occasionally, a lumbar puncture is done to check the fluid around the brain and spinal cord. CSF is usually normal in CMT2P. A markedly abnormal CSF suggests another or additional autoimmune or inflammatory process, not pure hereditary CMT.PMC+1
Electrodiagnostic tests
Electrodiagnostic studies are key tools to prove that the neuropathy is mainly axonal and length-dependent.
Nerve conduction studies (NCS)
In this test, small electrical pulses are given over a nerve, and the responses are recorded. In CMT2P and other axonal CMT2 forms, conduction speed may be near normal, but the amplitude (size) of the response is reduced because fewer axons are functioning. This pattern separates axonal CMT2 from demyelinating CMT1, where conduction is slow.PMC+2Europe PMC+2Electromyography (EMG)
EMG uses a fine needle electrode placed in muscles to record electrical activity at rest and with movement. In CMT2P, EMG often shows chronic denervation (loss of nerve supply) and reinnervation patterns typical of a length-dependent axonal neuropathy. It also helps rule out primary muscle disease.PMC+2Europe PMC+2Quantitative sensory testing (QST)
QST uses controlled temperature or vibration stimuli to measure sensory thresholds more precisely than a bedside exam. It can show early loss of vibration or temperature sensation in the feet and help track progression over time in research or specialized clinics.Europe PMC+2CMT Research Foundation+2
Imaging tests
Imaging tests do not diagnose CMT2P by themselves but give useful extra information.
MRI of leg muscles
Magnetic resonance imaging (MRI) of the lower legs can show which muscles are wasted and replaced by fat. Certain patterns of muscle changes have been reported in LRSAM1-related CMT2P and can support the diagnosis or distinguish it from other neuromuscular diseases.Idival+2PMC+2Spine MRI to rule out other causes of weakness and sensory loss
Because spinal cord disease can also cause leg weakness and numbness, doctors sometimes order a spine MRI to make sure there is no compression or other spinal problem. A normal spine MRI supports the idea that symptoms come from peripheral nerves such as in CMT2P.Orthobullets+2NINDS+2Foot and ankle X-rays
Simple X-rays of the feet and ankles can show high arches, hammertoes, and other deformities caused by long-term muscle imbalance. These images help orthopedic surgeons and physiatrists plan braces, shoe inserts, or surgery if needed, and indirectly support the diagnosis of a chronic peripheral neuropathy.Orthobullets+2Mayo Clinic+2
Non-Pharmacological Treatments (Therapies and Others)
Physiotherapy and stretching programs are one of the most important non-drug treatments. A physiotherapist designs gentle exercises to keep muscles as strong and flexible as possible, focusing on ankles, knees, hips, and core muscles. The purpose is to slow contractures, improve walking pattern, and maintain independence in daily activities. The mechanism is simple: repeated movement and stretching help preserve muscle fibers that are still working and prevent tendons from shortening as nerves slowly weaken. PMC+2nhs.uk+2
Strength training with low to moderate resistance aims to build and maintain muscle power without causing over-fatigue. Exercises often use body weight, light weights, or resistance bands tailored to the individual. The purpose is to improve standing, walking, stair climbing, and hand use. The mechanism is that consistent, moderate resistance encourages surviving motor units to adapt, improving their efficiency and preventing rapid deconditioning, which can otherwise worsen weakness in CMT. PMC+1
Balance and gait training focuses on practicing safe walking, turning, and standing on different surfaces. Therapists may use balance boards, parallel bars, and simple home exercises. The purpose is to reduce falls and build confidence in movement. The mechanism is motor learning: by repeating specific tasks, the brain and remaining nerves learn to compensate for lost sensation and weakness, creating safer movement patterns. PMC+1
Orthoses and walking aids, such as ankle-foot orthoses (AFOs), insoles, custom shoes, canes, or trekking poles, help stabilize weak ankles and high-arched or flat feet. Their purpose is to support joints, improve alignment, and make walking more energy-efficient. Mechanistically, braces hold the foot in a neutral position, preventing it from dropping during swing phase and improving push-off, which reduces tripping and joint strain. nhs.uk+1
Occupational therapy for hands and daily activities teaches adaptive strategies for dressing, writing, using phones, and working with weak or clumsy hands. The purpose is to maintain independence at home, school, and work. Mechanistically, occupational therapists recommend assistive devices (e.g., built-up pens, button hooks, special keyboards) and task-simplification techniques that reduce effort, protect joints, and bypass fine-motor deficits. PMC+1
Foot care, podiatry, and nail care are essential because numb feet can develop injuries without being noticed. Regular visits to a podiatrist help manage calluses, nail problems, and pressure points. The purpose is to prevent ulcers, infections, and deformities. The mechanism is early detection and off-loading: by removing pressure and treating small problems early, serious complications like chronic ulcers and osteomyelitis can often be avoided. nhs.uk+1
Pain psychology, cognitive behavioral therapy (CBT), and relaxation help people cope with chronic neuropathic pain and fatigue. The purpose is not to say “pain is in your head,” but to change the brain’s response to pain signals, reduce anxiety and depression, and improve sleep. Mechanistically, CBT and relaxation techniques such as breathing exercises and guided imagery modulate pain perception pathways and lower stress hormones, which can make pain feel less overwhelming. Charcot-Marie-Tooth Association+1
Lifestyle exercise (walking, cycling, swimming) provides general fitness without excessive joint stress. Low-impact aerobic activities improve heart and lung function, mood, and endurance for daily tasks. The mechanism is that regular aerobic activity improves blood flow to nerves and muscles, enhances mitochondrial function, and can reduce fatigue and pain sensitivity over time. The program must be individualized to avoid over-exertion. Charcot-Marie-Tooth Association+1
Weight management and healthy nutrition help by reducing the load on weak muscles and joints, especially feet and ankles. The purpose is to make movement easier and lower the risk of diabetes and cardiovascular disease, which can worsen neuropathy. The mechanism is simple energy balance: a diet rich in fruits, vegetables, lean protein, fiber, and healthy fats supports overall nerve health and reduces pro-inflammatory states that may aggravate symptoms. Charcot-Marie-Tooth Association+1
Fall-prevention and home safety modifications can include grab bars, non-slip mats, good lighting, and removing loose rugs or clutter. The purpose is to cut down on fractures, head injuries, and fear of falling. The mechanism is environmental control: by changing the surroundings rather than the person, the risk of accidents drops even if weakness and numbness are still present. PMC+1
Genetic counseling and family planning support help patients and relatives understand inheritance patterns (autosomal dominant or recessive), recurrence risk, and testing options. The purpose is informed decision-making around having children and screening family members. The mechanism is education: by explaining how LRSAM1 mutations are passed on, families can plan testing, early rehabilitation, and participation in research if they wish. Genetic Rare Diseases Center+2MalaCards+2
Peer support groups and patient organizations such as national CMT associations provide education, emotional support, and advocacy for research. The purpose is to reduce isolation and share practical tips for living with CMT. The mechanism is social connection: hearing from others with similar problems improves coping, adherence to therapy, and overall quality of life. Charcot-Marie-Tooth Association+1
Drug Treatments
Very important: medicines for CMT2P mainly treat symptoms like neuropathic pain, muscle cramps, mood problems, and sleep issues. They do not fix the gene defect or cure the disease. All doses below are general adult examples from FDA or guideline sources; exact dose and timing must be decided only by a neurologist or pain specialist for each person. Mayo Clinic+2Government of British Columbia+2
Pregabalin (Lyrica) is an anticonvulsant that calms over-active nerve cells. It is FDA-approved for several neuropathic pain conditions, such as diabetic peripheral neuropathy and post-herpetic neuralgia. Typical adult doses range from about 150–600 mg per day in divided doses, adjusted for kidney function. The purpose is to reduce burning, shooting pain and improve sleep. Mechanistically, pregabalin binds to the α2δ subunit of voltage-gated calcium channels, reducing release of excitatory neurotransmitters in pain pathways. Common side effects include dizziness, sleepiness, weight gain, and swelling in legs. FDA Access Data+2FDA Access Data+2
Gabapentin (Neurontin) is another anticonvulsant used widely for chronic neuropathic pain. It is FDA-approved for post-herpetic neuralgia and as add-on therapy for partial seizures, and is often used off-label for other neuropathic pains. Typical adult doses may range from 900–3600 mg per day split into three doses. Its purpose is to reduce nerve shooting pain and allodynia. Mechanistically, like pregabalin, it binds to the α2δ subunit of calcium channels, dampening excitatory neurotransmission. Side effects can include dizziness, drowsiness, swelling, and sometimes mood changes. Government of British Columbia+1
Duloxetine (Cymbalta) is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant that is also FDA-approved for diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Usual adult doses are around 60–120 mg once daily. The purpose is to treat both neuropathic pain and associated depression or anxiety. Mechanistically, duloxetine increases serotonin and norepinephrine in spinal pain pathways, enhancing descending pain inhibition. Side effects may include nausea, dry mouth, sweating, increased blood pressure, and, rarely, liver issues. Government of British Columbia+2PMC+2
Tricyclic antidepressants (e.g., amitriptyline, nortriptyline) are older antidepressants often used in low doses at bedtime (10–75 mg) for neuropathic pain and sleep. Their purpose is to reduce burning pain and help people fall asleep. Mechanistically, they block serotonin and norepinephrine reuptake and also modulate sodium and calcium channels, which reduces pain signaling. Side effects can include dry mouth, constipation, blurred vision, weight gain, and heart rhythm changes, so heart screening is important in older adults. Government of British Columbia+1
Venlafaxine and other SNRIs can be options when duloxetine or TCAs are not tolerated. At moderate doses, venlafaxine boosts serotonin and norepinephrine, which may ease neuropathic pain. The purpose is similar: treat mood symptoms and pain together. Mechanistically, these medicines strengthen descending inhibition of pain in the spinal cord. Side effects may include nausea, increased blood pressure, and withdrawal symptoms if stopped suddenly. Government of British Columbia+1
Topical lidocaine (patches or gels) provides local numbing to painful areas of skin, such as the top of the foot. A common regimen is applying a 5% patch for up to 12 hours in 24 hours to limited body surface area. The purpose is to cut down on surface allodynia without major systemic effects. Mechanistically, lidocaine blocks voltage-gated sodium channels in peripheral nerves, interrupting pain signal generation. Side effects are usually mild skin irritation or rash. ScienceDirect+1
Topical capsaicin (cream or high-dose patch) is derived from chili peppers and can be used for localized neuropathic pain. It first causes a burning sensation, then desensitizes TRPV1 receptors on pain fibers. The purpose is to reduce pain in small areas like the dorsum of the foot. Mechanistically, repeated exposure leads to depletion of substance P and temporary functional loss of small nociceptive fibers, which reduces pain signals. Side effects include transient burning and redness at the application site. ScienceDirect+1
Non-steroidal anti-inflammatory drugs (NSAIDs) like naproxen or ibuprofen can help with musculoskeletal pain, cramps, or joint strain caused by abnormal gait. Typical adult doses vary (for example, ibuprofen 400–800 mg every 6–8 hours with a maximum daily limit). Their purpose is more for muscle and joint pain than true neuropathic pain. Mechanistically, NSAIDs inhibit cyclo-oxygenase enzymes, lowering prostaglandin production and inflammation. Side effects include stomach irritation, ulcer risk, kidney strain, and increased cardiovascular risk with long-term high-dose use. Mayo Clinic+1
Muscle relaxants (e.g., baclofen, tizanidine) may be used if there is spasticity or painful muscle spasms. Baclofen is often started at low doses (5–10 mg three times daily) and titrated up. The purpose is to relieve stiffness and night cramps. Mechanistically, baclofen activates GABA-B receptors in the spinal cord, reducing excitatory neurotransmission to muscles. Side effects can include drowsiness, weakness, and dizziness. UpToDate+1
Short-term tramadol or other weak opioids may be considered for severe, refractory pain when first-line medicines fail, but they are generally avoided long-term due to dependence and side-effect risks. The purpose is to “rescue” patients during flares while other strategies are optimized. Mechanistically, tramadol acts as a weak μ-opioid agonist and also inhibits serotonin and norepinephrine reuptake. Side effects include nausea, constipation, dizziness, and risk of addiction or serotonin syndrome when combined with other serotonergic drugs. ScienceDirect+1
Sleep and mood medications (e.g., low-dose melatonin for sleep, SSRIs for depression) may be used to treat associated symptoms that worsen pain and disability. The purpose is holistic management: better sleep and mood can significantly reduce perceived pain and improve function. Mechanistically, these drugs adjust neurotransmitter levels or circadian rhythm signaling. Side effects depend on the specific medicine and must be monitored by the prescribing doctor. Charcot-Marie-Tooth Association+1
Dietary Molecular Supplements
Important: supplements cannot cure CMT2P and should only be used under medical supervision, especially if other medicines are taken. Evidence is modest and often indirect, but some nutrients may support general nerve health. UpToDate+1
Vitamin B12 (methylcobalamin) is essential for myelin formation and DNA synthesis in nerve cells. In people with deficiency, injections or high-dose oral tablets (often 1000 µg daily or as directed) can improve neuropathy. Its function is to support myelin repair and reduce further nerve damage. Mechanistically, B12 participates in methylation reactions and myelin protein synthesis; deficiency leads to demyelination and axonal degeneration. UpToDate
B-complex vitamins (B1, B6, B12) are sometimes used together because they play roles in energy production and neurotransmitter synthesis. Typical doses are in standard B-complex tablets within recommended daily allowances, avoiding very high B6 doses which can itself cause neuropathy. Their function is supportive metabolic co-factors for neurons. Mechanistically, they help enzymes in carbohydrate and amino acid metabolism, supporting axon energy supply. UpToDate
Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy, often at doses around 300–600 mg/day in adults. Its function is to reduce oxidative stress and possibly improve nerve blood flow. Mechanistically, alpha-lipoic acid scavenges free radicals and regenerates other antioxidants, improving mitochondrial function in nerves. Government of British Columbia+1
Omega-3 fatty acids (EPA/DHA) from fish oil or algae supplements are typically taken in doses of 1–3 g/day of combined EPA/DHA, depending on cardiovascular risk and doctor advice. Their function is anti-inflammatory and cardio-protective, which may indirectly help nerve health. Mechanistically, they are incorporated into cell membranes, modulating inflammatory eicosanoid production and improving membrane fluidity. Charcot-Marie-Tooth Association+1
Vitamin D is often supplemented when blood levels are low, with dosing based on lab results (for example, 800–2000 IU/day or higher short-term under supervision). Its function is bone health and immune modulation, important because weak people with falls risk need strong bones. Mechanistically, vitamin D receptors in immune cells and neurons influence calcium homeostasis and inflammation. UpToDate
Coenzyme Q10 (CoQ10) is part of the mitochondrial electron transport chain. Typical supplement doses are 100–300 mg/day in adults. Its function is to support mitochondrial energy production in nerves and muscles. Mechanistically, CoQ10 helps generate ATP and acts as an antioxidant within membranes, which may protect axons from energy failure. UpToDate
Regenerative, Immunity-Related and Stem-Cell-Oriented Approaches
For LRSAM1 CMT2P, no regenerative or stem cell drug is currently approved. Research in inherited neuropathies explores several approaches, mostly in early studies or animal models. These ideas must only be considered as part of clinical trials. Springer Link+2ScienceDirect+2
Gene-targeted therapies aim to correct or compensate for the faulty LRSAM1 gene, for example using viral vectors to deliver a healthy copy to peripheral nerves. The purpose is to stop or slow axonal degeneration at its root cause. Mechanistically, successful gene therapy would restore proper E3 ubiquitin ligase activity and protein quality control in neurons. At present, such therapies are experimental and not available in routine practice. Springer Link+1
Neurotrophic factor-based treatments (like NGF, NT-3, or other growth factors) are being studied to promote nerve regeneration and survival. The purpose is to make surviving neurons stronger and help regrow damaged axons. Mechanistically, these proteins bind to receptors on neurons, activating signaling pathways that support axon outgrowth and prevent apoptosis. Delivery and side effects are major challenges, so clinical use is still limited. Springer Link+1
Mesenchymal stem cell therapies from bone marrow or fat have been investigated in small studies for peripheral neuropathies. The purpose is to provide cells that secrete neuroprotective and anti-inflammatory factors. Mechanistically, these cells may home to injured nerves, release growth factors, and modulate immune responses, but engraftment into nerve tissue is limited. For CMT2P, this remains experimental and should only be done in approved clinical trials. Springer Link+1
Immunomodulatory treatments such as intravenous immunoglobulin (IVIG) or steroids are not standard for CMT2P, because it is genetic, not autoimmune. However, they may be used if an overlapping immune neuropathy is suspected. The purpose is to treat the immune component, not the inherited CMT itself. Mechanistically, these therapies change immune cell function and antibody activity. UpToDate
Surgeries
Corrective foot and ankle surgery is often considered when braces no longer provide enough support or when deformities, such as high arches (pes cavus), claw toes, or severe instability, cause pain and falls. Common procedures include tendon transfers, calcaneal osteotomy, and sometimes triple arthrodesis to make the foot more plantigrade. The purpose is to improve walking, reduce pain, and allow lighter braces. Mechanistically, surgery rebalances muscle forces and realigns bones so the foot can bear weight more evenly. pulse.cedars-sinai.org+5PMC+5Charcot-Marie-Tooth Association+5
Tendon lengthening or release (e.g., Achilles tendon) may be done when calf muscles are very tight and pull the heel up, leading to toe-walking or difficulty placing the foot flat. The purpose is to increase ankle dorsiflexion and improve gait. Mechanistically, cutting or lengthening the tendon reduces muscle tension, allowing the ankle joint to move through a more normal range and reducing compensatory strain on knees and hips. nmd-journal.com+1
Hand surgery or tendon transfers in the upper limb are less common but may help selected patients with severe hand weakness and clawing deformities. The purpose is to improve pinch and grasp. Mechanistically, surgeons reroute tendons from stronger muscles to replace the function of paralyzed ones, improving overall hand function even though underlying nerve disease persists. PMC+1
Prevention Strategies
Prevention in CMT2P mainly means preventing complications and extra damage, not stopping the gene mutation itself. People are advised to avoid medications known to be toxic to peripheral nerves (such as certain chemotherapy agents) when alternatives exist. The purpose is to avoid “second hits” on already fragile nerves. Mechanistically, reducing exposure to neurotoxic drugs lowers the risk of rapid worsening. UpToDate+1
Maintaining a healthy weight, regular low-impact exercise, and good control of other illnesses like diabetes or thyroid disease is strongly recommended. These steps reduce stress on muscles and joints and prevent additional acquired neuropathies. Mechanistically, better metabolic health improves blood flow and reduces oxidative and inflammatory stress on nerves. UpToDate+1
Good foot care and protective footwear help prevent ulcers, calluses, and fractures. This includes daily foot checks, well-fitting shoes with cushioning, and quick treatment of any skin breaks. Mechanistically, early management prevents small injuries from turning into deep infections and deformities. nhs.uk+1
Early and consistent physiotherapy and bracing from the time of diagnosis can delay deformities and maintain mobility. Mechanistically, supporting weak joints and stretching tight muscles slows structural changes and helps keep walking energy-efficient. PMC+1
Fall-proofing the home environment and using aids when needed prevent fractures and head injuries. Mechanistically, removing hazards and providing stable support reduces the chance of sudden, uncontrolled movements in someone with poor sensation and balance. PMC+1
Regular follow-up with a CMT-experienced team allows early detection of new problems, such as worsening deformity or painful contractures, so that treatments like orthotics or surgery can be timed well. Mechanistically, proactive monitoring prevents long periods of uncontrolled progression. PMC+2ScienceDirect+2
When to See Doctors
A person with known or suspected LRSAM1 CMT2P should see a neurologist or neuromuscular specialist if they notice new or rapidly worsening weakness, balance problems, foot deformity, hand clumsiness, or severe pain. Early assessment helps confirm diagnosis with nerve conduction studies and genetic testing and allows timely rehabilitation. Genetic Rare Diseases Center+2MalaCards+2
Urgent medical care is important if there are frequent falls, fractures, new bladder or bowel problems, sudden severe back pain, or significant mood changes such as depression or thoughts of self-harm. These signs may indicate complications or a different condition overlapping with CMT that needs treatment. UpToDate+1
Regular annual or semi-annual check-ups with physiatrists, physiotherapists, and orthotists are helpful to adjust braces, review exercise plans, and decide if and when surgery is appropriate. PMC+2enmc.org+2
What to Eat and What to Avoid
A balanced diet rich in vegetables, fruits, whole grains, lean protein (fish, poultry, legumes), nuts, and seeds supports overall health and helps maintain a healthy weight, which is important for weak muscles and joints. Adequate protein helps maintain muscle mass, while colorful plant foods provide antioxidants that may protect nerves from oxidative stress. Charcot-Marie-Tooth Association+1
It is wise to limit highly processed foods, sugary drinks, and excess saturated or trans fats, which can contribute to obesity, insulin resistance, and cardiovascular disease. These conditions worsen circulation and can aggravate neuropathy symptoms. Keeping added sugar and refined carbohydrates low helps with long-term metabolic health. UpToDate+1
Moderate intake of omega-3-rich foods, such as fatty fish (salmon, sardines, mackerel), flaxseeds, and walnuts, may provide anti-inflammatory benefits. Choosing olive or canola oil over solid animal fats can further support heart and vessel health. Charcot-Marie-Tooth Association+1
People are usually advised to avoid heavy alcohol use and smoking, as both can damage peripheral nerves and blood vessels and significantly worsen neuropathy. Even in genetic neuropathies, these lifestyle factors can speed decline. UpToDate+1
Because some supplements interact with medicines, all vitamins, herbal products, and “nerve tonics” should be discussed with the treating doctor or pharmacist before use. UpToDate
Frequently Asked Questions
1. Is LRSAM1 CMT2P curable?
No. At present there is no cure. Treatments focus on keeping you as active, independent, and comfortable as possible through therapy, braces, pain control, and sometimes surgery. Genetic Rare Diseases Center+2MalaCards+2
2. Will I end up in a wheelchair?
Many people with CMT walk for life with braces and therapy, though some may eventually need a wheelchair for longer distances. The course is very variable and usually slow, and early rehabilitation improves long-term mobility. Genetic Rare Diseases Center+1
3. Do medicines stop the disease from progressing?
Current medicines mainly treat pain, cramps, mood, and sleep. They do not change the underlying gene problem or fully stop progression, but they can greatly improve quality of life. Mayo Clinic+2Government of British Columbia+2
4. Are there special drugs approved just for CMT2P?
No drug is yet specifically approved for CMT2P. Drugs like pregabalin, gabapentin, and duloxetine are approved for other neuropathic pain conditions and used to treat similar pain in CMT. FDA Access Data+2Government of British Columbia+2
5. Can exercise make the nerves worse?
Gentle, supervised exercise is considered safe and helpful. Over-training with heavy loads or to the point of extreme fatigue is not advised. A physiotherapist can design a safe program. PMC+2Charcot-Marie-Tooth Association+2
6. Should I have surgery early?
Surgery is usually considered when foot deformity or pain is severe and braces are not enough. Timing depends on age, deformity, and daily limitations. An orthopedic surgeon familiar with CMT should evaluate you. Mayo Clinic+3PMC+3Charcot-Marie-Tooth Association+3
7. Is pregnancy safe for someone with CMT2P?
Many people with CMT have successful pregnancies, but weakness and balance issues may worsen temporarily. Genetic counseling is useful to discuss inheritance risks and plan monitoring. Genetic Rare Diseases Center+2MalaCards+2
8. Can children be tested for LRSAM1 mutations?
Genetic testing is possible, but decisions about testing minors should be made carefully with genetic counselors, considering emotional impact and practical benefit. Genetic Rare Diseases Center+2MalaCards+2
9. Do supplements really help?
Supplements like B12 or vitamin D help most when there is a true deficiency. For others, evidence is limited. They should be seen as supportive, not as a main treatment, and always checked with your doctor. UpToDate+1
10. Can I prevent my children from getting CMT2P?
You cannot change your genes, but options such as prenatal diagnosis or pre-implantation genetic testing may be discussed with specialists. Genetic counseling explains these possibilities in detail. Genetic Rare Diseases Center+2MalaCards+2
11. Will CMT2P affect my heart or brain?
CMT2P mainly affects peripheral motor and sensory nerves. It usually does not directly damage the brain or heart, though balance problems can cause falls and injuries. Genetic Rare Diseases Center+1
12. Is pain always present in CMT2P?
Some people have significant neuropathic pain, others have mainly numbness and weakness with little pain. Pain level varies widely and can change over time. Genetic Rare Diseases Center+1
13. Are research studies or trials available?
Clinical trials investigating gene therapy, new drugs, or rehabilitation strategies for CMT are ongoing in some centers. A neuromuscular specialist or patient organization can help you learn about active studies. ScienceDirect+2Hospital for Special Surgery+2
14. What specialists should be on my care team?
Ideally you have a neurologist, physiatrist, physiotherapist, occupational therapist, orthotist, orthopedic surgeon, psychologist, and genetic counselor, all familiar with CMT. PMC+2UpToDate+2
15. What is the most important thing I can do today?
The most helpful steps are to stay as active as is safely possible, protect your feet, use braces and aids if recommended, manage pain with your doctor’s guidance, and look after your mental health and social connections. These actions together can greatly improve daily life with LRSAM1 CMT2P. PMC+2Charcot-Marie-Tooth Association+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
